A parallel phenomenon was observed in malignant melanoma by Mrad et al., who demonstrated that inhibition of SPHK1 (the key enzyme catalysing sphingosine conversion to S1P) decreased M2 macrophage prevalence while increasing M1 macrophage proportions within the tumour niche. Here, SPHK1 is linked to melanoma.